Annual Current Liabilities
$38.52 M
-$572.00 K-1.46%
December 31, 2024
Summary
- As of March 10, 2025, FATE annual total current liabilities is $38.52 million, with the most recent change of -$572.00 thousand (-1.46%) on December 31, 2024.
- During the last 3 years, FATE annual current liabilities has fallen by -$42.76 million (-52.61%).
- FATE annual current liabilities is now -66.22% below its all-time high of $114.05 million, reached on December 31, 2022.
Performance
FATE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$38.52 M
+$1.10 M+2.94%
December 31, 2024
Summary
- As of March 10, 2025, FATE quarterly total current liabilities is $38.52 million, with the most recent change of +$1.10 million (+2.94%) on December 31, 2024.
- Over the past year, FATE quarterly current liabilities has increased by +$1.10 million (+2.94%).
- FATE quarterly current liabilities is now -66.22% below its all-time high of $114.05 million, reached on December 31, 2022.
Performance
FATE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
FATE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.5% | +2.9% |
| 3 y3 years | -52.6% | +2.9% |
| 5 y5 years | +38.5% | +2.9% |
FATE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.2% | at low | -66.2% | +10.7% |
| 5 y | 5-year | -66.2% | +38.5% | -66.2% | +54.6% |
| alltime | all time | -66.2% | +948.2% | -66.2% | +910.5% |
Fate Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $38.52 M(-1.5%) | $38.52 M(+2.9%) |
| Sep 2024 | - | $37.42 M(+7.6%) |
| Jun 2024 | - | $34.79 M(-23.3%) |
| Mar 2024 | - | $45.37 M(+16.1%) |
| Dec 2023 | $39.09 M(-65.7%) | $39.09 M(-5.4%) |
| Sep 2023 | - | $41.33 M(-7.5%) |
| Jun 2023 | - | $44.69 M(-8.1%) |
| Mar 2023 | - | $48.65 M(-57.3%) |
| Dec 2022 | $114.05 M(+40.3%) | $114.05 M(+9.7%) |
| Sep 2022 | - | $103.94 M(+13.6%) |
| Jun 2022 | - | $91.52 M(+17.5%) |
| Mar 2022 | - | $77.91 M(-4.1%) |
| Dec 2021 | $81.28 M(-5.0%) | $81.28 M(-11.5%) |
| Sep 2021 | - | $91.88 M(-13.0%) |
| Jun 2021 | - | $105.60 M(+11.7%) |
| Mar 2021 | - | $94.58 M(+10.5%) |
| Dec 2020 | $85.56 M(+207.7%) | $85.56 M(+57.9%) |
| Sep 2020 | - | $54.20 M(+19.6%) |
| Jun 2020 | - | $45.32 M(+81.8%) |
| Mar 2020 | - | $24.92 M(-10.4%) |
| Dec 2019 | $27.81 M(+2.0%) | $27.81 M(-31.5%) |
| Sep 2019 | - | $40.59 M(+38.0%) |
| Jun 2019 | - | $29.42 M(+1.0%) |
| Mar 2019 | - | $29.14 M(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $27.26 M(+146.7%) | $27.26 M(+20.2%) |
| Sep 2018 | - | $22.67 M(+39.3%) |
| Jun 2018 | - | $16.27 M(+29.3%) |
| Mar 2018 | - | $12.59 M(+13.9%) |
| Dec 2017 | $11.05 M(-27.2%) | $11.05 M(+13.7%) |
| Sep 2017 | - | $9.72 M(+20.7%) |
| Jun 2017 | - | $8.05 M(-52.3%) |
| Mar 2017 | - | $16.90 M(+11.3%) |
| Dec 2016 | $15.19 M(+13.0%) | $15.19 M(+3.5%) |
| Sep 2016 | - | $14.68 M(+2.4%) |
| Jun 2016 | - | $14.33 M(+3.2%) |
| Mar 2016 | - | $13.89 M(+3.3%) |
| Dec 2015 | $13.44 M(+194.1%) | $13.44 M(+6.7%) |
| Sep 2015 | - | $12.60 M(+11.3%) |
| Jun 2015 | - | $11.31 M(+76.4%) |
| Mar 2015 | - | $6.41 M(+40.3%) |
| Dec 2014 | $4.57 M(-0.7%) | $4.57 M(+16.8%) |
| Sep 2014 | - | $3.91 M(+2.6%) |
| Jun 2014 | - | $3.81 M(-12.4%) |
| Mar 2014 | - | $4.35 M(-5.3%) |
| Dec 2013 | $4.60 M(-5.2%) | $4.60 M(-51.5%) |
| Sep 2013 | - | $9.49 M(+74.9%) |
| Jun 2013 | - | $5.43 M(+11.9%) |
| Dec 2012 | $4.85 M(+32.0%) | $4.85 M |
| Dec 2011 | $3.67 M | - |
FAQ
- What is Fate Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Fate Therapeutics?
- What is Fate Therapeutics annual current liabilities year-on-year change?
- What is Fate Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Fate Therapeutics?
- What is Fate Therapeutics quarterly current liabilities year-on-year change?
What is Fate Therapeutics annual total current liabilities?
The current annual current liabilities of FATE is $38.52 M
What is the all time high annual current liabilities for Fate Therapeutics?
Fate Therapeutics all-time high annual total current liabilities is $114.05 M
What is Fate Therapeutics annual current liabilities year-on-year change?
Over the past year, FATE annual total current liabilities has changed by -$572.00 K (-1.46%)
What is Fate Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FATE is $38.52 M
What is the all time high quarterly current liabilities for Fate Therapeutics?
Fate Therapeutics all-time high quarterly total current liabilities is $114.05 M
What is Fate Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FATE quarterly total current liabilities has changed by +$1.10 M (+2.94%)